摘要
目的:探究黄精四草汤联合氨氯地平对阴虚阳亢型高血压病患者的临床效果分析。方法:选取佛山市第一人民医院禅城医院在2017年5月-2018年9月收治的92例阴虚阳亢型高血压病患者作为研究对象,随机分为研究组和对照组,每组46例。对照组使用氨氯地平治疗,研究组在对照组的基础上加入中药黄精四草汤。观察两组患者的血压和血脂变化,以及治疗总有效率并进行对比。结果:研究组患者的降压效果显著优于对照组(P<0.05);研究组患者治疗符合收缩压和舒张压正常值的患者人数显著高于对照组(P<0.05);研究组患者的血脂指标改善情况明显优于对照组(P<0.05)。结论:对于阴虚阳亢高血压病患者来说,采用黄精四草汤与氨氯地平联合治疗的方法,能够有效地降低患者的血压,患者的收缩压和舒张压也逐渐地在正常范围之内,治疗效果显著,值得在临床上大面积推广运用。
Objective:To explore the clinical effect of Huangjing Sicao Decoction(黄精四草汤)combined with amlodipine on patients with Yin deficiency and Yang hyperactivity type hypertension.Methods:92 patients with Yin deficiency and Yang hyperactivity hypertension admitted to our hospital from may,2017 to September,2018 were selected as research subjects and randomly divided into the study group and the control group,with 46 patients in each group.The control group was treated with amlodipine,and the study group received Huangjing Sicao Decoction combined with amlodipine.The changes of blood pressure and lipid in the two groups were observed,and the effective rate of treatment was compared.Results:The antihypertensive effect of the study group was significantly better than that of the control group(P<0.05);The number of patients with normal systolic and diastolic blood pressure in the study group was significantly higher than that in the control group(P<0.05);The improvement of blood lipid index in the study group was significantly better than that in the control group(P<0.05).Conclusion:For hypertension patients with Yin deficiency and Yang hyperactivity,Huangjing Sicao Decoction combined with amlodipine can effectively reduce the patients’blood pressure,and the patients’systolic blood pressure and diastolic blood pressure are also gradually within the normal range,and the treatment effect is very significant,which is worthy of extensive promotion and application in clinical practice.
出处
《中医临床研究》
2020年第6期52-53,70,共3页
Clinical Journal Of Chinese Medicine
关键词
黄精四草汤
氨氯地平
阴虚阳亢型高血压病患者
Huangjing Sicao Decoction
Amlodipine
Patients with Yin deficiency and Yang hyperactivity type hypertension
